These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10163394)

  • 21. Permeability of alginate microcapsules to secretory recombinant gene products.
    Awrey DE; Tse M; Hortelano G; Chang PL
    Biotechnol Bioeng; 1996 Nov; 52(4):472-84. PubMed ID: 18629920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel method to enhance the stability of alginate-poly-L-lysine-alginate microcapsules.
    Wang MS; Childs RF; Chang PL
    J Biomater Sci Polym Ed; 2005; 16(1):91-113. PubMed ID: 15796307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of engineered cells for implantation in gene therapy.
    Bowie KM; Chang PL
    Adv Drug Deliv Rev; 1998 Aug; 33(1-2):31-43. PubMed ID: 10837651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel approach to tumor suppression with microencapsulated recombinant cells.
    Cirone P; Bourgeois JM; Austin RC; Chang PL
    Hum Gene Ther; 2002 Jul; 13(10):1157-66. PubMed ID: 12133269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microencapsulation of recombinant cells: a new delivery system for gene therapy.
    Tai IT; Sun AM
    FASEB J; 1993 Aug; 7(11):1061-9. PubMed ID: 8370477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of human factor IX by microencapsulated recombinant fibroblasts.
    Liu HW; Ofosu FA; Chang PL
    Hum Gene Ther; 1993 Jun; 4(3):291-301. PubMed ID: 8338876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer strategies for correction of lysosomal storage disorders.
    D'Azzo A
    Acta Haematol; 2003; 110(2-3):71-85. PubMed ID: 14583667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain.
    Ross CJ; Chang PL
    J Biomater Sci Polym Ed; 2002; 13(8):953-62. PubMed ID: 12463513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease.
    Pauly DF; Fraites TJ; Toma C; Bayes HS; Huie ML; Hirschhorn R; Plotz PH; Raben N; Kessler PD; Byrne BJ
    Hum Gene Ther; 2001 Mar; 12(5):527-38. PubMed ID: 11268285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo culture of encapsulated endostatin-secreting Chinese hamster ovary cells for systemic tumor inhibition.
    Zhang Y; Wang W; Xie Y; Yu W; Teng H; Liu X; Zhang X; Guo X; Fei J; Ma X
    Hum Gene Ther; 2007 May; 18(5):474-81. PubMed ID: 17518615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microcapsules prepared with different biomaterials to immobilize GDNF secreting 3T3 fibroblasts.
    Ponce S; Orive G; Gascón AR; Hernández RM; Pedraz JL
    Int J Pharm; 2005 Apr; 293(1-2):1-10. PubMed ID: 15778039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases.
    Matte U; Lagranha VL; de Carvalho TG; Mayer FQ; Giugliani R
    J Inherit Metab Dis; 2011 Oct; 34(5):983-90. PubMed ID: 21614584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():99-109. PubMed ID: 24380128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene transfer may be preventive but not curative for a lysosomal transport disorder.
    Hippert C; Dubois G; Morin C; Disson O; Ibanes S; Jacquet C; Schwendener R; Antignac C; Kremer EJ; Kalatzis V
    Mol Ther; 2008 Aug; 16(8):1372-81. PubMed ID: 18578013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells.
    Cirone P; Bourgeois JM; Shen F; Chang PL
    Hum Gene Ther; 2004 Oct; 15(10):945-59. PubMed ID: 15585110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
    Rando TA; Blau HM
    J Cell Biol; 1994 Jun; 125(6):1275-87. PubMed ID: 8207057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swine.
    Cheng WT; Chen BC; Chiou ST; Chen CM
    Hum Gene Ther; 1998 Sep; 9(14):1995-2003. PubMed ID: 9759927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of recombinant product from subcutaneous implants of encapsulated recombinant cells in canines.
    Stockley TL; Robinson KE; Delaney K; Ofosu FA; Chang PL
    J Lab Clin Med; 2000 Jun; 135(6):484-92. PubMed ID: 10850648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases.
    Zafir-Lavie I; Sherbo S; Goltsman H; Badinter F; Yeini E; Ofek P; Miari R; Tal O; Liran A; Shatil T; Krispel S; Shapir N; Neil GA; Benhar I; Panet A; Satchi-Fainaro R
    J Control Release; 2018 Dec; 291():80-89. PubMed ID: 30342077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.